Prestige Consumer Healthcare (PBH) Competitors

Prestige Consumer Healthcare (NYSE:PBH) and Inter Parfums (NASDAQ:IPAR) are both mid-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their dividends, valuation, institutional ownership, risk, profitability, earnings, media sentiment, community ranking and analyst recommendations.

Which has more risk and volatility, PBH or IPAR?

Prestige Consumer Healthcare has a beta of 0.47, meaning that its stock price is 53% less volatile than the S&P 500. Comparatively, Inter Parfums has a beta of 1.15, meaning that its stock price is 15% more volatile than the S&P 500.

Do analysts recommend PBH or IPAR?

Prestige Consumer Healthcare currently has a consensus price target of $93.33, indicating a potential upside of 13.13%. Inter Parfums has a consensus price target of $157.60, indicating a potential upside of 44.53%. Given Inter Parfums' stronger consensus rating and higher probable upside, analysts plainly believe Inter Parfums is more favorable than Prestige Consumer Healthcare.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Prestige Consumer Healthcare	0 Sell rating(s)	3 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.50
Inter Parfums	0 Sell rating(s)	0 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	3.00

Which has stronger earnings and valuation, PBH or IPAR?

Prestige Consumer Healthcare has higher earnings, but lower revenue than Inter Parfums. Prestige Consumer Healthcare is trading at a lower price-to-earnings ratio than Inter Parfums, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Prestige Consumer Healthcare	$1.12B	3.65	$209.34M	$4.27	19.32
Inter Parfums	$1.45B	2.41	$152.65M	$5.09	21.42

Do institutionals and insiders have more ownership in PBH or IPAR?

99.9% of Prestige Consumer Healthcare shares are owned by institutional investors. Comparatively, 55.6% of Inter Parfums shares are owned by institutional investors. 1.6% of Prestige Consumer Healthcare shares are owned by company insiders. Comparatively, 43.9% of Inter Parfums shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Does the MarketBeat Community favor PBH or IPAR?

Prestige Consumer Healthcare received 27 more outperform votes than Inter Parfums when rated by MarketBeat users. Likewise, 70.30% of users gave Prestige Consumer Healthcare an outperform vote while only 65.19% of users gave Inter Parfums an outperform vote.

Company	Underperform	Outperform
Prestige Consumer Healthcare	Outperform Votes 497 70.30%	Underperform Votes 210 29.70%
Inter Parfums	Outperform Votes 470 65.19%	Underperform Votes 251 34.81%

Is PBH or IPAR a better dividend stock?

Prestige Consumer Healthcare pays an annual dividend of $1.90 per share and has a dividend yield of 2.3%. Inter Parfums pays an annual dividend of $3.20 per share and has a dividend yield of 2.9%. Prestige Consumer Healthcare pays out 44.5% of its earnings in the form of a dividend. Inter Parfums pays out 62.9% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years.

Does the media prefer PBH or IPAR?

In the previous week, Prestige Consumer Healthcare had 4 more articles in the media than Inter Parfums. MarketBeat recorded 11 mentions for Prestige Consumer Healthcare and 7 mentions for Inter Parfums. Inter Parfums' average media sentiment score of 1.22 beat Prestige Consumer Healthcare's score of 1.01 indicating that Inter Parfums is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Prestige Consumer Healthcare	3 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Inter Parfums	5 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Is PBH or IPAR more profitable?

Prestige Consumer Healthcare has a net margin of 19.13% compared to Inter Parfums' net margin of 10.60%. Inter Parfums' return on equity of 16.34% beat Prestige Consumer Healthcare's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Prestige Consumer Healthcare	19.13%	12.36%	6.39%
Inter Parfums	10.60%	16.34%	10.82%

Summary

Inter Parfums beats Prestige Consumer Healthcare on 12 of the 20 factors compared between the two stocks.